LEI: 213800XJIPNDVKXMOC11
3 May 2023
HIPGNOSIS SONGS FUND LIMITED
(the "Company" or "Hipgnosis")
DIRECTORATE CHANGE
The Board of Hipgnosis, the first UK listed investment company offering investors a pure-play exposure to songs and associated musical intellectual property rights, and its Investment Adviser, Hipgnosis Song Management Limited, announce that Vania Schlogel has stepped down as a Director of the Company with effect from 30 April 2023 to focus on her executive role at Atwater Capital, which she founded in 2017 and for which her commitments and responsibilities have recently increased significantly.
Merck Mercuriadis, CEO and Founder of Hipgnosis Song Management and Founder of Hipgnosis Songs Fund said:
"Vania is an exceptional executive and her experience in every aspect of investment and music has been invaluable in making Hipgnosis the market leader. We appreciate her terrific contributions to Hipgnosis Songs Fund during her time on the Board and wish her every success in the future."
Andrew Sutch, Chair, Hipgnosis Songs Fund, said:
"On behalf of the Board, I would like to thank Vania Schlogel for her important contribution to the Company and we wish Vania and Atwater Capital all possible success."
For further information, please contact:
Hipgnosis Song Management Limited Merck Mercuriadis Giles Croot (Media) Rufina Pavry (Investors) |
+44 (0)20 4542 1511 +44 (0)20 4542 1530
|
Singer Capital Markets - Joint Corporate Broker James Moat / James Maxwell / Alex Emslie (Corporate Finance) Alan Geeves / James Waterlow / Sam Greatrex (Sales)
|
+44 (0)20 7496 3000 |
J.P. Morgan Cazenove - Joint Corporate Broker William Simmonds / Jérémie Birnbaum (Corporate Finance) James Bouverat (Sales)
|
+44 (0)20 7742 4000 |
RBC Capital Markets - Joint Corporate Broker Elliot Thomas / Max Avison (Corporate Finance) Lisa Tugwell / Anastasia Mikhailova (Sales)
|
+44 (0)20 7635 4000 |
Ocorian - Company Secretary & Administrator Lorna Zimny
|
+44 (0) 28 9693 0222 |
The Outside Organisation Alan Edwards / Nick Caley
|
+44 (0)7711 081 843 |
FTI Consulting Neil Doyle/ Paul Harris/ Laura Ewart |
+44 (0)7771 978220; +44 (0)7809 411882; +44 (0)7761 332646 |
All US music publicity enquiries Fran Defeo |
+1 917 767 5255 |
|
|
|
|
|
|
NOTES TO EDITORS
About Hipgnosis Songs Fund Limited
Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. The Company has raised a total of almost £1.3 billion (gross equity capital) through its Initial Public Offering on 11 July 2018, and subsequent issues in April 2019, August 2019, October 2019, July 2020, September 2020, February 2021 and July 2021. In September 2019, Hipgnosis transferred its entire issued share capital to the Premium listing segment of the Official List of the FCA and to the London Stock Exchange's Premium segment of the Main Market, and in March 2020 became a constituent of the FTSE 250 Index. Since April 2021, the Company has been resident in the UK for tax purposes and is recognised as an investment trust under applicable HMRC regulations.
About Hipgnosis Song Management Limited
The Company's Investment Adviser is Hipgnosis Song Management Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of Hipgnosis Song Management Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, David A. Stewart, Poo Bear, Bill Leibowitz, Ian Montone and Rodney Jerkins.